From NASDAQ.: 2024-04-27 05:50:00

In some ways, investing is like baking. With the right mix of stocks, you can grow a sizable portfolio. Amazon (NASDAQ: AMZN) boasts a strong moat and multiple growth avenues for exceptional long-term returns. Meanwhile, MercadoLibre (NASDAQ: MELI) thrives in the Latin American market with a focus on e-commerce and fintech. Vertex Pharmaceuticals (NASDAQ: VRTX) shows promising growth potential with its pipeline of innovative therapies.

Amazon’s network effect and brand strength give it a solid moat for continued growth. MercadoLibre benefits from e-commerce growth in Latin America and its position as a market leader in the region. Vertex Pharmaceuticals’ success in cystic fibrosis treatments and upcoming gene-editing therapies set the stage for significant expansion.

With e-commerce and cloud hosting businesses, Amazon has room for continued growth. MercadoLibre’s dominance in Latin America’s logistics and fintech sectors provides a strategic advantage. Vertex Pharmaceuticals’ leadership in treating genetic disorders and chronic diseases signals long-term success in the biopharmaceutical industry.

John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, sits on The Motley Fool’s board of directors. The author holds positions in Amazon, MercadoLibre, and Vertex Pharmaceuticals. The Motley Fool recommends and discloses positions in these companies.



Read more at NASDAQ.: Want $1 Million in Retirement? 3 Stocks to Buy Now And Hold for Decades.